Outcome of pregnancies in women with thrombophilic disorders

References

• Brenner B. 2003. Inherited thrombophilia and pregnancy loss. Best Practice and Research in Clinical Haematology 16:311–320.
   PubMed Web of Science ®Google Scholar
• Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. 2000. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thrombosis and Haemostasis 83:693–697.
   PubMed Web of Science ®Google Scholar
• Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J; LIVE-ENOX Investigators. 2005. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis 3:227–229.
   PubMed Web of Science ®Google Scholar
• Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. 1999. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thrombosis and Haemostasis 82:6–9.
   PubMed Web of Science ®Google Scholar
• Carp H, Dolitzky M, Inbal A. 2003. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. Journal of Thrombosis and Haemostasis 1:433–438.
   PubMed Web of Science ®Google Scholar
• Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, et al. 2005. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstetrics and Gynecology 106:517–524.
   PubMed Web of Science ®Google Scholar
• Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, et al. 2000. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductases C677T, are associated with recurrent miscarriages. Human Reproduction (Oxford, England) 15:458–462.
   PubMed Web of Science ®Google Scholar
• Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, Holm JP, et al. 2007. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. British Journal of Haematology 136:656–661.
   PubMed Web of Science ®Google Scholar
• Galli M, Barbui T. 2003. Antiphospholipid antibodies and pregnancy. Best Practice and Research in Clinical Haematology 16:211–225.
   PubMed Web of Science ®Google Scholar
• Grandone E, De Stefano V, Rossi E, Cappucci F, Colaizzo D, Margaglione M. 2008. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagulation and Fibrinolysis 19:226–230.
   PubMed Web of Science ®Google Scholar
• Greer I, Hunt BJ. 2005. Low molecular weight heparin in pregnancy: current issues. British Journal of Haematology 128:593–601.
   PubMed Web of Science ®Google Scholar
• Greer IA, Nelson-Piercy C. 2005. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106:401–407.
   PubMed Web of Science ®Google Scholar
• Gris JC, Mercier E, Quéré I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, et al. 2004. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103:3695–3699.
   PubMed Web of Science ®Google Scholar
• Gris JC, Quéré I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, et al. 1999. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent – the Nîmes Obstetricians and Haematologists Study5 (NOHA5). Thrombosis and Haemostasis 81:891–899.
   PubMed Web of Science ®Google Scholar
• Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. 2004. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Archives of Internal Medicine 164:558–563.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, et al. 2001. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertension in Pregnancy 20:35–44.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. 1999. Increased frequency of genetic thrombophilia in women with complications of pregnancy. New England Journal of Medicine 340:9–13.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. 2000. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstetricia et Gynecologica Scandinavica 79:963–967.
   PubMed Web of Science ®Google Scholar
• Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C, et al. 2001. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. British Journal of Obstetrics and Gynaecology 108:1134–1140.
   Google Scholar
• Lindqvist PG, Merlo J. 2006. The natural course of women with recurrent fetal loss. Journal of Thrombosis and Haemostasis 4:896–897.
   PubMed Web of Science ®Google Scholar
• Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ. 2001. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstetrics and Gynecology 98:1041–1014.
   PubMed Web of Science ®Google Scholar
• Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. 2000. Mutations in coagulation factors in women with unexplained late fetal loss. New England Journal of Medicine 343:1015–1018.
   PubMed Web of Science ®Google Scholar
• Middeldorp S. 2007. Thrombophilia and pregnancy complications: cause or association? Journal of Thrombosis and Haemostasis 5:276–282.
   PubMed Web of Science ®Google Scholar
• Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, et al. 1999. Increased risk for fetal loss in carriers of the factor V Leiden mutation. Annals of Internal Medicine 130:736–739.
   PubMed Web of Science ®Google Scholar
• Pabinger I, Vormittag R. 2005. Thrombophilia and pregnancy outcomes. Journal of Thrombosis and Haemostasis 3:1603–1610.
   PubMed Web of Science ®Google Scholar
• Preston FE, Rosendaal FR, Walker ID, Briët E, Berntorp E, Conard J, et al. 1996. Increased fetal loss in women with heritable thrombophilia. Lancet 348:913–916.
   PubMed Web of Science ®Google Scholar
• Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, et al. 2001. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Human Reproduction (Oxford, England) 16:961–965.
   PubMed Web of Science ®Google Scholar
• Regan L, Braude PR, Trembath PL. 1989. Influence of past reproductive performance on risk of spontaneous abortion. British Medical Journal 299:541–545.
   PubMed Web of Science ®Google Scholar
• Rey E, Kahn SR, David M, Shrier I. 2003. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361:901–908.
   PubMed Web of Science ®Google Scholar
• Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. 2006. Thrombophilia in pregnancy: a systematic review. British Journal of Haematology 132:171–196.
   PubMed Web of Science ®Google Scholar
• Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM. 1995. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. American Journal of Obstetrics and Gynecology 173:1049–1057.
   PubMed Web of Science ®Google Scholar
• Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hilsman MV, Girolami A, et al. 1996. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein-S deficient women. Thrombosis and Haemostasis 75:387–388.
   PubMed Web of Science ®Google Scholar
• Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. 2002. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertility and Sterility 77:342–347.
   PubMed Web of Science ®Google Scholar
• Vossen CY, Preston FE, Conard J, Fontcuberta J, Makris M, van Der Meer FJ, et al. 2004. Hereditary thrombophilia and fetal loss: a prospective follow-up study. Journal of Thrombosis and Haemostasis 2:592–596.
   PubMed Web of Science ®Google Scholar
• Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M. 2000. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. American Journal of Reproductive Immunology 43:31–35.
   PubMed Web of Science ®Google Scholar